Examining The Visual Outcome And Intraocular Pressure Changes In Postoperative PCO Cases In Patients With And Without Diabetes

Abstract

The leading long-term risk associated with contemporary IOL surgery is posterior capsular opacification. The standard of care for its treatment is the Nd: YAG laser. This research aims to evaluate the visual outcomes and changes in intraocular pressure (IOP) between diabetic and non-diabetic individuals after Nd:YAG laser capsulotomy. Taking place at Khaja Banda Nawaz Teaching and General Hospital in Kalaburgai, this prospective research included 100 patients, 50 of whom had diabetes and 50 of whom had not. We performed Nd:YAG laser capsulotomy on all patients (45–75 years old) seen in our routine outpatient clinic who had noticeable posterior capsular opacification. Patients who met the inclusion and exclusion criteria were enrolled in the trial. Improvements in BCVA and changes in IOP were documented during patient follow-ups on the first day, first week, and four weeks.
Visual acuity improved in every single patient treated for PCO with Nd:YAG laser capsulotomy. When compared to the first week (34%), and first day (16%), the visual result after four weeks (41% had > 6/12) was determined to be superior. Those without diabetes had a superior end visual result at 4 weeks (52% had > 6/12) than those with diabetes (30%). Both groups of patients had a similar pattern of rise in intraocular pressure (IOP) on first day and first week of follow-up, which returned to near baseline levels at four weeks of follow-up.
When it comes to individuals with visually significant PCO, Nd:YAG laser capsulotomy is a great way to enhance visual acuity. The alterations in retinopathy are the reason why the diabetic group had a rather worse result. IOP temporarily rises after Nd:YAG laser capsulotomy, however it almost never stays high.